help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, N.
Right arrow Articles by Suda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, N.
Right arrow Articles by Suda, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*1,25-DIHYDROXYCHOLECALCIFEROL
*CALCITONIN, SALMON

Endocrinology, Vol 123, 2600-2602, Copyright © 1988 by Endocrine Society

ARTICLES

Osteoblastic cells are involved in osteoclast formation

N Takahashi, T Akatsu, N Udagawa, T Sasaki, A Yamaguchi, JM Moseley, TJ Martin and T Suda
Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan.

We developed a co-culture system with mouse spleen cells and osteoblastic cells to examine the role of osteoblasts in osteoclast formation. When mouse spleen cells and osteoblastic cells isolated from fetal mouse calvariae were co-cultured in the presence of 10 nM 1 alpha, 25-dihydroxyvitamin D3 [1 alpha,25(OH)2D3], numerous tartrate- resistant acid phosphate (TRACP)-positive mononuclear and multinucleated cells were formed within 8 days. Neither the same co- cultures without the vitamin nor separate cultures of either spleen cells or osteoblastic cells with the vitamin produced TRACP-positive cells. Salmon calcitonin (CT) markedly increased cAMP production in the co-cultures treated with 1 alpha,25(OH)2D3. Autoradiographic studies clearly demonstrated that [125I]-CT specifically bound to the TRACP- positive cells formed in the co-cultures with the vitamin. When spleen cells and osteoblastic cells were co-cultured on dentine slices in the presence of 1 alpha,25(OH)2D3, numerous resorption lacunae were formed on the slices. Neither co-cultures of alveolar macrophages and osteoblastic cells nor those of spleen cells and mouse skin-derived fibroblasts induced TRACP-positive cells even in the presence of 1 alpha,25(OH)2D3. When spleen cells and osteoblastic cells were cultured separately from each other by a membrane filter (0.45 micron), no TRACP- positive cells were formed. These results indicate that osteoblastic cells are required for the differentiation of osteoclast progenitors in splenic tissues into multinucleated osteoclasts.


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
J. Lorenzo, M. Horowitz, and Y. Choi
Osteoimmunology: Interactions of the Bone and Immune System
Endocr. Rev., June 1, 2008; 29(4): 403 - 440.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
H K Datta, W F Ng, J A Walker, S P Tuck, and S S Varanasi
The cell biology of bone metabolism
J. Clin. Pathol., May 1, 2008; 61(5): 577 - 587.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. E. Kearns, S. Khosla, and P. J. Kostenuik
Receptor Activator of Nuclear Factor {kappa}B Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
Endocr. Rev., April 1, 2008; 29(2): 155 - 192.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J.-P. Li, H. Kajiya, F. Okamoto, A. Nakao, T. Iwamoto, and K. Okabe
Three Na+/Ca2+ Exchanger (NCX) Variants Are Expressed in Mouse Osteoclasts and Mediate Calcium Transport during Bone Resorption
Endocrinology, May 1, 2007; 148(5): 2116 - 2125.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Hikita, I. Yana, H. Wakeyama, M. Nakamura, Y. Kadono, Y. Oshima, K. Nakamura, M. Seiki, and S. Tanaka
Negative Regulation of Osteoclastogenesis by Ectodomain Shedding of Receptor Activator of NF-{kappa}B Ligand
J. Biol. Chem., December 1, 2006; 281(48): 36846 - 36855.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. N. Pearse
Wnt antagonism in multiple myeloma: a potential cause of uncoupled bone remodeling.
Clin. Cancer Res., October 15, 2006; 12(20): 6274s - 6278s.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Mochizuki, M. Takami, T. Kawawa, R. Suzumoto, T. Sasaki, A. Shiba, H. Tsukasaki, B. Zhao, R. Yasuhara, T. Suzawa, et al.
Identification and Characterization of the Precursors Committed to Osteoclasts Induced by TNF-Related Activation-Induced Cytokine/Receptor Activator of NF-{kappa}B Ligand
J. Immunol., October 1, 2006; 177(7): 4360 - 4368.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. A. Fretz, L. A. Zella, S. Kim, N. K. Shevde, and J. W. Pike
1,25-Dihydroxyvitamin D3 Regulates the Expression of Low-Density Lipoprotein Receptor-Related Protein 5 via Deoxyribonucleic Acid Sequence Elements Located Downstream of the Start Site of Transcription
Mol. Endocrinol., September 1, 2006; 20(9): 2215 - 2230.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Ghosh-Choudhury, P. K. Singha, K. Woodruff, P. S. Clair, S. Bsoul, S. L. Werner, and G. G. Choudhury
Concerted Action of Smad and CREB-binding Protein Regulates Bone Morphogenetic Protein-2-stimulated Osteoblastic Colony-stimulating Factor-1 Expression
J. Biol. Chem., July 21, 2006; 281(29): 20160 - 20170.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
N. Normanno and W. J Gullick
Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application?
Endocr. Relat. Cancer, March 1, 2006; 13(1): 3 - 6.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. Take, Y. Kobayashi, Y. Yamamoto, H. Tsuboi, T. Ochi, S. Uematsu, N. Okafuji, S. Kurihara, N. Udagawa, and N. Takahashi
Prostaglandin E2 Strongly Inhibits Human Osteoclast Formation
Endocrinology, December 1, 2005; 146(12): 5204 - 5214.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. C. J. van der Eerden, J. G. J. Hoenderop, T. J. de Vries, T. Schoenmaker, C. J. Buurman, A. G. Uitterlinden, H. A. P. Pols, R. J. M. Bindels, and J. P. T. M. van Leeuwen
The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption
PNAS, November 29, 2005; 102(48): 17507 - 17512.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Kim, K. Sato, M. Asagiri, I. Morita, K. Soma, and H. Takayanagi
Contribution of Nuclear Factor of Activated T Cells c1 to the Transcriptional Control of Immunoreceptor Osteoclast-associated Receptor but Not Triggering Receptor Expressed by Myeloid Cells-2 during Osteoclastogenesis
J. Biol. Chem., September 23, 2005; 280(38): 32905 - 32913.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Yang, N. Takahashi, T. Yamashita, N. Sato, M. Takahashi, M. Mogi, T. Uematsu, Y. Kobayashi, Y. Nakamichi, K. Takeda, et al.
Muramyl Dipeptide Enhances Osteoclast Formation Induced by Lipopolysaccharide, IL-1{alpha}, and TNF-{alpha} through Nucleotide-Binding Oligomerization Domain 2-Mediated Signaling in Osteoblasts
J. Immunol., August 1, 2005; 175(3): 1956 - 1964.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Kobayashi, I. Take, T. Yamashita, T. Mizoguchi, T. Ninomiya, T. Hattori, S. Kurihara, H. Ozawa, N. Udagawa, and N. Takahashi
Prostaglandin E2 Receptors EP2 and EP4 Are Down-regulated during Differentiation of Mouse Osteoclasts from Their Precursors
J. Biol. Chem., June 24, 2005; 280(25): 24035 - 24042.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
N Normanno, A De Luca, D Aldinucci, M R Maiello, M Mancino, A D'Antonio, R De Filippi, and A Pinto
Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis
Endocr. Relat. Cancer, June 1, 2005; 12(2): 471 - 482.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Kobayashi, T. Mizoguchi, I. Take, S. Kurihara, N. Udagawa, and N. Takahashi
Prostaglandin E2 Enhances Osteoclastic Differentiation of Precursor Cells through Protein Kinase A-dependent Phosphorylation of TAK1
J. Biol. Chem., March 25, 2005; 280(12): 11395 - 11403.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. Tolar, S. L. Teitelbaum, and P. J. Orchard
Osteopetrosis
N. Engl. J. Med., December 30, 2004; 351(27): 2839 - 2849.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Matsumoto, M. Kogawa, S. Wada, H. Takayanagi, M. Tsujimoto, S. Katayama, K. Hisatake, and Y. Nogi
Essential Role of p38 Mitogen-activated Protein Kinase in Cathepsin K Gene Expression during Osteoclastogenesis through Association of NFATc1 and PU.1
J. Biol. Chem., October 29, 2004; 279(44): 45969 - 45979.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. J. Frew, N. A. Sims, J. M. W. Quinn, C. R. Walkley, L. E. Purton, D. D. L. Bowtell, and M. T. Gillespie
Osteopenia in Siah1a Mutant Mice
J. Biol. Chem., July 9, 2004; 279(28): 29583 - 29588.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Hirotani, N. A. Tuohy, J.-T. Woo, P. H. Stern, and N. A. Clipstone
The Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway Regulates Osteoclastogenesis in RAW264.7 Cells
J. Biol. Chem., April 2, 2004; 279(14): 13984 - 13992.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Suda, N. Udagawa, N. Sato, M. Takami, K. Itoh, J.-T. Woo, N. Takahashi, and K. Nagai
Suppression of Osteoprotegerin Expression by Prostaglandin E2 Is Crucially Involved in Lipopolysaccharide-Induced Osteoclast Formation
J. Immunol., February 15, 2004; 172(4): 2504 - 2510.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Niida, M. Kawahara, Y. Ishizuka, Y. Ikeda, T. Kondo, T. Hibi, Y. Suzuki, K. Ikeda, and N. Taniguchi
{gamma}-Glutamyltranspeptidase Stimulates Receptor Activator of Nuclear Factor-{kappa}B Ligand Expression Independent of Its Enzymatic Activity and Serves as a Pathological Bone-resorbing Factor
J. Biol. Chem., February 13, 2004; 279(7): 5752 - 5756.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
T. Kikuchi, Y. Yoshikai, J. Miyoshi, M. Katsuki, T. Musikacharoen, A. Mitani, S. Tanaka, T. Noguchi, and T. Matsuguchi
Cot/Tpl2 is Essential for RANKL Induction by Lipid A in Osteoblasts
J. Dent. Res., July 1, 2003; 82(7): 546 - 550.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Liu, Z. Shi, A. Silveira, J. Liu, M. Sawadogo, H. Yang, and X. Feng
Involvement of Upstream Stimulatory Factors 1 and 2 in RANKL-induced Transcription of Tartrate-resistant Acid Phosphatase Gene during Osteoclast Differentiation
J. Biol. Chem., May 30, 2003; 278(23): 20603 - 20611.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. S. Ahuja, S. Zhao, T. Bellido, L. I. Plotkin, F. Jimenez, and L. F. Bonewald
CD40 Ligand Blocks Apoptosis Induced by Tumor Necrosis Factor {alpha}, Glucocorticoids, and Etoposide in Osteoblasts and the Osteocyte-Like Cell Line Murine Long Bone Osteocyte-Y4
Endocrinology, May 1, 2003; 144(5): 1761 - 1769.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Itoh, N. Udagawa, K. Kobayashi, K. Suda, X. Li, M. Takami, N. Okahashi, T. Nishihara, and N. Takahashi
Lipopolysaccharide Promotes the Survival of Osteoclasts Via Toll-Like Receptor 4, but Cytokine Production of Osteoclasts in Response to Lipopolysaccharide Is Different from That of Macrophages
J. Immunol., April 1, 2003; 170(7): 3688 - 3695.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Nakamichi, C. Shukunami, T. Yamada, K.-i. Aihara, H. Kawano, T. Sato, Y. Nishizaki, Y. Yamamoto, M. Shindo, K. Yoshimura, et al.
Chondromodulin I Is a Bone Remodeling Factor
Mol. Cell. Biol., January 15, 2003; 23(2): 636 - 644.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
B.-K. Choi, H. J. Lee, J. H. Kang, G. J. Jeong, C. K. Min, and Y.-J. Yoo
Induction of Osteoclastogenesis and Matrix Metalloproteinase Expression by the Lipooligosaccharide of Treponema denticola
Infect. Immun., January 1, 2003; 71(1): 226 - 233.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Takeuchi, S. Watanabe, G. Ishii, S. Takeda, K. Nakayama, S. Fukumoto, Y. Kaneta, D. Inoue, T. Matsumoto, K. Harigaya, et al.
Interleukin-11 as a Stimulatory Factor for Bone Formation Prevents Bone Loss with Advancing Age in Mice
J. Biol. Chem., December 6, 2002; 277(50): 49011 - 49018.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
N. K. Shevde, L. A. Plum, M. Clagett-Dame, H. Yamamoto, J. W. Pike, and H. F. DeLuca
A potent analog of 1alpha ,25-dihydroxyvitamin D3 selectively induces bone formation
PNAS, October 15, 2002; 99(21): 13487 - 13491.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S.-K. Lee, J. Kalinowski, S. Jastrzebski, and J. A. Lorenzo
1,25 (OH)2 Vitamin D3-Stimulated Osteoclast Formation in Spleen-Osteoblast Cocultures Is Mediated in Part by Enhanced IL-1{alpha} and Receptor Activator of NF-{kappa}B Ligand Production in Osteoblasts
J. Immunol., September 1, 2002; 169(5): 2374 - 2380.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
X. Li, N. Udagawa, K. Itoh, K. Suda, Y. Murase, T. Nishihara, T. Suda, and N. Takahashi
p38 MAPK-Mediated Signals Are Required for Inducing Osteoclast Differentiation But Not for Osteoclast Function
Endocrinology, August 1, 2002; 143(8): 3105 - 3113.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Ishida, N. Fujita, R. Kitazawa, and T. Tsuruo
Transforming Growth Factor-beta Induces Expression of Receptor Activator of NF-kappa B Ligand in Vascular Endothelial Cells Derived from Bone
J. Biol. Chem., July 12, 2002; 277(29): 26217 - 26224.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
H. Nakamura, T. Tsuji, A. Hirata, and T. Yamamoto
Localization of Osteoprotegerin (OPG) on Bone Surfaces and Cement Lines in Rat Tibia
J. Histochem. Cytochem., July 1, 2002; 50(7): 945 - 954.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. L. Abboud, K. Woodruff, C. Liu, V. Shen, and N. Ghosh-Choudhury
Rescue of the Osteopetrotic Defect in op/op Mice by Osteoblast-Specific Targeting of Soluble Colony-Stimulating Factor-1
Endocrinology, May 1, 2002; 143(5): 1942 - 1949.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
H Sakai, S Jingushi, T Shuto, K Urabe, T Ikenoue, K Okazaki, T Kukita, A Kukita, and Y Iwamoto
Fibroblasts from the inner granulation tissue of the pseudocapsule in hips at revision arthroplasty induce osteoclast differentiation, as do stromal cells
Ann Rheum Dis, February 1, 2002; 61(2): 103 - 109.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Khosla
Minireview: The OPG/RANKL/RANK System
Endocrinology, December 1, 2001; 142(12): 5050 - 5055.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Yagishita, Y. Yamamoto, T. Yoshizawa, K. Sekine, Y. Uematsu, H. Murayama, Y. Nagai, W. Krezel, P. Chambon, T. Matsumoto, et al.
Aberrant Growth Plate Development in VDR/RXR{gamma} Double Null Mutant Mice
Endocrinology, December 1, 2001; 142(12): 5332 - 5341.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. Brown, R. L. Vessella, P. J. Kostenuik, C. R. Dunstan, P. H. Lange, and E. Corey
Serum Osteoprotegerin Levels Are Increased in Patients with Advanced Prostate Cancer
Clin. Cancer Res., October 1, 2001; 7(10): 2977 - 2983.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. D. Roodman
Biology of Osteoclast Activation in Cancer
J. Clin. Oncol., August 1, 2001; 19(15): 3562 - 3571.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Itoh, N. Udagawa, T. Katagiri, S. Iemura, N. Ueno, H. Yasuda, K. Higashio, J. M. W. Quinn, M. T. Gillespie, T. J. Martin, et al.
Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-{kappa}B Ligand
Endocrinology, August 1, 2001; 142(8): 3656 - 3662.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Kikuchi, T. Matsuguchi, N. Tsuboi, A. Mitani, S. Tanaka, M. Matsuoka, G. Yamamoto, T. Hishikawa, T. Noguchi, and Y. Yoshikai
Gene Expression of Osteoclast Differentiation Factor Is Induced by Lipopolysaccharide in Mouse Osteoblasts Via Toll-Like Receptors
J. Immunol., March 1, 2001; 166(5): 3574 - 3579.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
L. Xing, A. M. Venegas, A. Chen, L. Garrett-Beal, B. F. Boyce, H. E. Varmus, and P. L. Schwartzberg
Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival
Genes & Dev., January 15, 2001; 15(2): 241 - 253.
[Abstract] [Full Text]

Home page
 J. Exp. Biol.Home page
C Faucheux, S Nesbitt, M Horton, and J Price
Cells in regenerating deer antler cartilage provide a microenvironment that supports osteoclast differentiation
J. Exp. Biol., January 2, 2001; 204(3): 443 - 455.
[Abstract] [PDF]

Home page
 EndocrinologyHome page
F. Gori, L. C. Hofbauer, C. R. Dunstan, T. C. Spelsberg, S. Khosla, and B. L. Riggs
The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated
Endocrinology, December 1, 2000; 141(12): 4768 - 4776.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Udagawa, N. Takahashi, H. Yasuda, A. Mizuno, K. Itoh, Y. Ueno, T. Shinki, M. T. Gillespie, T. J. Martin, K. Higashio, et al.
Osteoprotegerin Produced by Osteoblasts Is an Important Regulator in Osteoclast Development and Function
Endocrinology, September 1, 2000; 141(9): 3478 - 3484.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
X. Li, Y. Okada, C. C. Pilbeam, J. A. Lorenzo, C. R. J. Kennedy, R. M. Breyer, and L. G. Raisz
Knockout of the Murine Prostaglandin EP2 Receptor Impairs Osteoclastogenesis in Vitro
Endocrinology, June 1, 2000; 141(6): 2054 - 2061.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
T. Miyazaki, H. Katagiri, Y. Kanegae, H. Takayanagi, Y. Sawada, A. Yamamoto, M. P. Pando, T. Asano, I. M. Verma, H. Oda, et al.
Reciprocal Role of ERK and NF-{kappa}B Pathways in Survival and Activation of Osteoclasts
J. Cell Biol., January 24, 2000; 148(2): 333 - 342.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
F. Arai, T. Miyamoto, O. Ohneda, T. Inada, T. Sudo, K. Brasel, T. Miyata, D. M. Anderson, and T. Suda
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of c-Fms and Receptor Activator of Nuclear Factor {kappa}B (RANK) Receptors
J. Exp. Med., December 20, 1999; 190(12): 1741 - 1754.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. J. Thomas, T. A. Guise, J. J. Yin, J. Elliott, N. J. Horwood, T. J. Martin, and M. T. Gillespie
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation
Endocrinology, October 1, 1999; 140(10): 4451 - 4458.
[Abstract] [Full Text]

Home page
 BloodHome page
A. Kukita, T. Kukita, M. Ouchida, H. Maeda, H. Yatsuki, and O. Kohashi
Osteoclast-Derived Zinc Finger (OCZF) Protein With POZ Domain, a Possible Transcriptional Repressor, Is Involved in Osteoclastogenesis
Blood, September 15, 1999; 94(6): 1987 - 1997.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Mbalaviele, N. Jaiswal, A. Meng, L. Cheng, C. Van Den Bos, and M. Thiede
Human Mesenchymal Stem Cells Promote Human Osteoclast Differentiation from CD34+ Bone Marrow Hematopoietic Progenitors
Endocrinology, August 1, 1999; 140(8): 3736 - 3743.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
D. Inoue, C. Shih, D. L. Galson, S. R. Goldring, W. C. Horne, and R. Baron
Calcitonin-Dependent Down-Regulation of the Mouse C1a Calcitonin Receptor in Cells of the Osteoclast Lineage Involves a Transcriptional Mechanism
Endocrinology, March 1, 1999; 140(3): 1060 - 1068.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
Y. Ogata, A. Kukita, T. Kukita, M. Komine, A. Miyahara, S. Miyazaki, and O. Kohashi
A Novel Role of IL-15 in the Development of Osteoclasts: Inability to Replace Its Activity with IL-2
J. Immunol., March 1, 1999; 162(5): 2754 - 2760.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Matsuzaki, K. Katayama, Y. Takahashi, I. Nakamura, N. Udagawa, T. Tsurukai, R. Nishinakamura, Y. Toyama, Y. Yabe, M. Hori, et al.
Human Osteoclast-Like Cells Are Formed from Peripheral Blood Mononuclear Cells in a Coculture with SaOS-2 Cells Transfected with the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Gene
Endocrinology, February 1, 1999; 140(2): 925 - 932.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
I. Nakamura, H. Tanaka, G. A. Rodan, and L. T. Duong
Echistatin Inhibits the Migration of Murine Prefusion Osteoclasts and the Formation of Multinucleated Osteoclast-Like Cells
Endocrinology, December 1, 1998; 139(12): 5182 - 5193.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. A. Corral, M. Amling, M. Priemel, E. Loyer, S. Fuchs, P. Ducy, R. Baron, and G. Karsenty
Dissociation between bone resorption and bone formation in osteopenic transgenic mice
PNAS, November 10, 1998; 95(23): 13835 - 13840.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Harada, T. Kukita, A. Kukita, Y. Iwamoto, and T. Iijima
Involvement of Lymphocyte Function-Associated Antigen-1 and Intercellular Adhesion Molecule-1 in Osteoclastogenesis: A Possible Role in Direct Interaction between Osteoclast Precursors
Endocrinology, September 1, 1998; 139(9): 3967 - 3975.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
B. S. Kwon, S. Wang, N. Udagawa, V. Haridas, Z. H. Lee, K. K. Kim, K.-o. Oh, J. Greene, Y. Li, J. Su, et al.
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption
FASEB J, July 1, 1998; 12(10): 845 - 854.
[Abstract] [Full Text]

Home page
 JCBHome page
G. Mbalaviele, R. Nishimura, A. Myoi, M. Niewolna, S. V. Reddy, D. Chen, J. Feng, D. Roodman, G. R. Mundy, and T. Yoneda
Cadherin-6 Mediates the Heterotypic Interactions between the Hemopoietic Osteoclast Cell Lineage and Stromal Cells in a Murine Model of Osteoclast Differentiation
J. Cell Biol., June 15, 1998; 141(6): 1467 - 1476.
[Abstract] [Full Text]